Advertisement

Abstract

Lysosomal storage diseases (LSDs) are a group of more than 50 inherited metabolic disorders that result from defective lysosomal acid hydrolysis of endogenous macromolecules causing their accumulation (Winchester et al. 2000). A classification based on the nature of the primary stored material involved is reported in Table 52.1. Actually it is well known that all LSDs are not simply due to this storage, but they result from the perturbation of complex cell-signaling mechanisms. Generally lysosomal storage disorders occur when lysosomes do not function properly. All lysosomal storage diseases are single-gene/single-enzyme disorders resulting in lysosomal dysfunction. Various metabolic substrates are involved: lipids, glycoproteins, and mucopolysaccharides. Most of LSDs are autosomal recessively inherited disorders, with only three exceptions: Fabry disease and Hunter disease (MPS II) are X-linked recessive, while Danon disease is X-linked dominant. To date, in the absence of newborn screening programs, true LSD incidence is not known. Although some pilot projects reported a higher incidence (Spada et al. 2006; Chien et al. 2008), individual LSDs occur with an incidence of less than 1:100.000, while as a group the incidence is about 1:7,700 (Meikle et al. 1999). Comprehensive quali/quantitative analysis of the entire panel of accumulation products is still not available due to the complexity and chemical diversity of the storage products involved in LSDs.

Keywords

Sialic Acid Fabry Disease Heterozygous Carrier Lysosomal Storage Disease Newborn Screening Program 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Abeling NG, Rusch H, van Gennip AH (1996) Improved selectivity of urinary oligosaccharide screening using two one-dimensional TLC systems. J Inherit Metab Dis 19:260–262PubMedCrossRefGoogle Scholar
  2. Auray-Blais C, Bhérer P, Gagnon R et al (2011) Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI. Mol Genet Metab 102:49–56PubMedCrossRefGoogle Scholar
  3. Blanchard S, Sadilek M, Scott CR et al (2008) Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis I. Clin Chem 54:2067–2070PubMedCentralPubMedCrossRefGoogle Scholar
  4. Chamoles NA, Blanco M, Gaggioli D (2001) Fabry disease: enzymatic diagnosis in dried blood spots on filter paper. Clin Chim Acta 308:195–196PubMedCrossRefGoogle Scholar
  5. Chien YH, Chiang SC, Zhang XK et al (2008) Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program. Pediatrics 122:39–45CrossRefGoogle Scholar
  6. de Jong JG, Wevers RA, Liebrand-van Sambeek R (1992) Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue. Clin Chem 38:803–807PubMedGoogle Scholar
  7. Duffey TA, Sadilek M, Scott CR et al (2010) Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Anal Chem 82:9587–9591PubMedCentralPubMedCrossRefGoogle Scholar
  8. Friedman RB, Williams MA, Moser HW et al (1978) Improved thin-layer chromatographic method in the diagnosis of mannosidosis. Clin Chem 24:1576–1577PubMedGoogle Scholar
  9. Fuller M, Tucker JN, Lang DL et al (2011) Screening patients referred to a metabolic clinic for lysosomal storage disorders. J Med Genet 48:422–425PubMedCrossRefGoogle Scholar
  10. Gelb MH, Turecek F, Scott CR et al (2006) Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders. J Inherit Metab Dis 29:397–404PubMedCentralPubMedCrossRefGoogle Scholar
  11. Guerrini M, Naggi A, Guglieri S et al (2005) Complex glycosaminoglycans: profiling substitution patterns by two-dimensional nuclear magnetic resonance spectroscopy. Anal Biochem 337:35–47PubMedCrossRefGoogle Scholar
  12. Humbel R, Collart M (1975) Oligosaccharides in urine of patients with glycoprotein storage diseases. I. Rapid detection by thin-layer chromatography. Clin Chim Acta 60(2):143–145PubMedCrossRefGoogle Scholar
  13. Khaliq T, Sadilek M, Scott CR et al (2011) Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis IVA. Clin Chem 57:128–131PubMedCentralPubMedCrossRefGoogle Scholar
  14. Kuberan B, Lech M, Zhang L et al (2002) Analysis of heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography microelectrospray ionization time-of-flight mass spectrometry. J Am Chem Soc 124:8707–8718PubMedCrossRefGoogle Scholar
  15. la Marca G, Casetta B, Malvagia S et al (2009) New strategy for the screening of lysosomal storage disorders: the use of the online trapping-and-cleanup liquid chromatography/mass spectrometry. Anal Chem 81:6113–6121PubMedCrossRefGoogle Scholar
  16. Lage S, Prieto JA, Andrade F et al (2011) Reliability of a visual test for the rapid detection of mucopolysaccharidoses: GAG-test(®). J Clin Lab Anal 25:179–184PubMedCrossRefGoogle Scholar
  17. Li Y, Scott CR, Chamoles NA et al (2004) Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening. Clin Chem 50(10):1785–1796PubMedCentralPubMedCrossRefGoogle Scholar
  18. Meikle PJ, Hopwood JJ, Clague AE et al (1999) Prevalence of lysosomal storage disorders. JAMA 281:249–254PubMedCrossRefGoogle Scholar
  19. Metz TF, Mechtler TP, Orsini JJ et al (2011) Simplified newborn screening protocol for lysosomal storage disorders. Clin Chem 57(9):1286–1294PubMedCrossRefGoogle Scholar
  20. Okamura-Oho Y, Yamanaka T, Suzuki Y et al (1984) A simple enzymatic determination of urinary sialic acid – its significance in the diagnosis of disorders of sialic acid metabolism. Clin Chim Acta 144:263–267PubMedCrossRefGoogle Scholar
  21. Palo J, Savolainen H (1972) Thin-layer chromatographic demonstration of aspartylglycosylamine and a novel acidic carbohydrate in human tissues. J Chromatogr 65:447–450PubMedCrossRefGoogle Scholar
  22. Ramsay SL, Meikle PJ, Hopwood JJ et al (2005) Profiling oligosaccharidurias by electrospray tandem mass spectrometry: quantifying reducing oligosaccharides. Anal Biochem 345:30–46PubMedCrossRefGoogle Scholar
  23. Saad OM, Leary JA (2005) Compositional analysis and quantification of heparin and heparan sulfate by electrospray ionization ion trap mass spectrometry. Anal Chem 75:2985–2995CrossRefGoogle Scholar
  24. Sewell AC (1981) Simple laboratory determination of excess oligosacchariduria. Clin Chem 27:243–245PubMedGoogle Scholar
  25. Sewell AC (2008) Oligosaccharides. In Blau N, Duran M, Gibson KM (ed) Laboratory Guide to the Methods in Biochemical Genetics, Springer. pp 325–333Google Scholar
  26. Spada M, Pagliardini S, Yasuda M et al (2006) High incidence of later-onset Fabry disease revealed by newborn screening. Am J Hum Genet 79:31–40PubMedCentralPubMedCrossRefGoogle Scholar
  27. Studelska DR, Giljum K, McDowell LM et al (2006) Quantification of glycosaminoglycans by reversed-phase HPLC separation of fluorescent isoindole derivatives. Glycobiology 16:65–72PubMedCrossRefGoogle Scholar
  28. Tsai MY, Marshall JG (1979) Screening for urinary oligosaccharides and simple sugars by thin-layer chromatography. Med Lab Sci 36:85–90PubMedGoogle Scholar
  29. van der Ham M, Prinsen BH, Huijmans JG et al (2007) Quantification of free and total sialic acid excretion by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 848:251–257PubMedCrossRefGoogle Scholar
  30. Volpi N, Maccari F (2006) Electrophoretic approaches to the analysis of complex polysaccharides. J Chromatogr B 834:1–13CrossRefGoogle Scholar
  31. Winchester B, Vellodi A, Young E (2000) The molecular basis of lysosomal storage diseases and their treatment. Biochem Soc Trans 28:150–154PubMedGoogle Scholar
  32. Wolfe BJ, Blanchard S, Sadilek M et al (2011) Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis II (Hunter Syndrome). Anal Chem 83:1152–1156PubMedCentralPubMedCrossRefGoogle Scholar
  33. Zhang XK, Elbin CS, Chuang WL et al (2008) Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry. Clin Chem 54:1725–1728PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Department of Neurosciences, Psychology, Pharmacology and Child HealthUniversity of FlorenceFlorenceItaly
  2. 2.Newborn Screening, Clinical Chemistry and Pharmacology LabMeyer Children’s HospitalFlorenceItaly

Personalised recommendations